Piper Sandler analyst Jason Bednar maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) today and set a price target of $94.00. The company’s shares closed yesterday at $84.31.
Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Envista Holdings, and Cooper Co. According to TipRanks, Bednar has an average return of -6.2% and a 35.37% success rate on recommended stocks.
Currently, the analyst consensus on GE Healthcare Technologies Inc is a Moderate Buy with an average price target of $97.10, which is a 15.17% upside from current levels. In a report released on April 11, Mizuho Securities also assigned a Buy rating to the stock with a $110.00 price target.
The company has a one-year high of $94.47 and a one-year low of $62.30. Currently, GE Healthcare Technologies Inc has an average volume of 3.55M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
GE Healthcare Technologies Inc (GEHC) Company Description:
GE HealthCare Technologies Inc is a global medical technology, pharmaceutical diagnostics, and digital solutions innovator company.
Read More on GEHC:
- GE Healthcare CEO Resigns, Successor Search Begins
- Early notable gainers among liquid option names on April 11th
- GE HealthCare price target raised to $110 from $96 at Mizuho
- GE vs. GEHC: Which General Electric Stock Is Better?
- GE Vernova Stock (NYSE:GEV): GE Spins Off an Electrifying Energy Business
